Among these, the hypermethylated FANCF promoter, resulting in a compromised FA signaling, was found in 6.7% to 30% of tested tumor cell lines including testis, lung, ovarian, and cervical cancer lines [73,74,75]. The gene discussed is FANCA; the disease is neoplasm.